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False-positive or false-negative results attributable to undetected genotyping errors and confounding factors present a constant challenge
for genome-wide association studies (GWAS) given the low signals associated with complex phenotypes and the noise associated with
high-throughput genotyping. In the context of the genetics of kidneys in diabetes (GoKinD) study, we identify a source of error in geno-
type calling and demonstrate that a standard battery of quality-control (QC) measures is not sufﬁcient to detect and/or correct it. We
show that, if genotyping and calling are done by plate (batch), even a few DNA samples of marginally acceptable quality can profoundly
alter the allele calls for other samples on the plate. In turn, this leads to signiﬁcant differential bias in estimates of allele frequency
between plates and, potentially, to false-positive associations, particularly when case and control samples are not sufﬁciently random-
ized to plates. This problem may become widespread as investigators tap into existing public databases for GWAS control samples. We
describe how to detect and correct this bias by utilizing additional sources of information, including raw signal-intensity data.The results reported here were obtained in the QC phase of
data analysis from the GoKinD study comprising DNA
samples andmore than 300 dichotomous and quantitative
variables related to nephropathy (the primary phenotype),
neuropathy, retinopathy, and cardiovascular disease; these
data were collected from more than 1,800 probands with
long-standing (10þ years) type 1 diabetes (T1D). After
selection for GWAS by the Genetic Association Informa-
tion Network (GAIN),1 the DNA samples were distributed
across 34 plates and genotyped on the Affymetrix
Genome-Wide Human SNP Array 5.0 platform (see Web
Resources). Probands were screened into two primary
phenotype categories: those with deﬁnitive kidney disease
(cases) and those without (controls). In addition, DNA and
phenotype data were collected from parents of 582
probands. Altogether, more than 3,000 samples were avail-
able for genotyping. The data on a subset of 1,825 individ-
uals containing genotype calls in ~460K SNPs, primary
phenotypes, and raw probe intensity (.CEL) ﬁles were
made available in September of 2007 to qualiﬁed investiga-
tors through dbGaP2 (see Web Resources) after NIH review
of the investigator request form.
The high cost of such large-scale sample and phenotype
collection and genotyping, the recognition that genetic
risk factors for phenotypes corresponding to diabetic
complications are expected to be of the same low to
moderate magnitude as those estimated for other complex
phenotypes,3 and the fact that the GoKinD study will be
a widely used public resource highlight the importance
of thorough QC testing. Although the signiﬁcance of QC
analysis has been noted in several GWAS3–5 and a number
of steps6–9 have emerged as a guideline for QC of GWAS,
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The Aa public source is somewhat different from conducting
QC in an experiment that is totally under the control of
the investigator. In the former, the investigator has no
input on decisions made previously, such as the choice of
platform, allele-calling algorithm, allele-calling protocol
(e.g., calling genotypes over the entire sample, smaller
batches, or by plate), or the randomization of subjects
across plates. Although quality public resources, such as
dbGaP, provide detailed information on experimental
design as well as probe-intensity data (e.g., .CEL ﬁles gener-
ated by the Affymetrix platforms) and thus facilitate the
development of innovative QC methods, this is by no
means a universal practice in current data-sharing proto-
cols. Our goal is to maximize quality, and elucidate limita-
tions, of data obtained from such sources outside of the
control of the investigator.
The QC analysis for GoKinD was carried out both at
NCBI with the GAINQC software package (see Web
Resources) prior to data release and by individual investiga-
tors. Alleles were called in batches by plate at the Broad
Institute with the Birdseed version 2 software10 (see Web
Resources). Filtering criteria applied to SNPs in the full
GoKinD data included a call rate >95%, an HWE test
p value >107, and a number of Mendelian incompatibil-
ities <3. Genotyped SNPs that had a known physical
map position and that passed these QC ﬁlters (427,350)
were used in subsequent analyses. Summary statistics
based on the ﬁltered data, as well as results of a plate-effect
test for assessing heterogeneity in allele frequencies across
plates, were also made available to investigators requesting
GoKinD data.
It was apparent from the beginning that the QC at NCBI
might not have been sufﬁcient to identify and correct allatistics, The University of Chicago, Chicago, IL 60637, USA; 4Department of
leston, SC 29425, USA; 5Center for Research and Evaluation, SUNY Upstate
Genetics. All rights reserved.
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Figure 1. Q-Q Plots of the log10(p
Value) for the Plate and Primary-Pheno-
type Association Test
The 1 df plate effect (top row) and pheno-
type association (bottom row) are shown
under the following three QC scenarios:
(A and D) standard QC, (B and E) standard
QC plus removal of the problem samples,
and (C and F) standard QC plus removal
of the problem samples and recall of the
affected plate. Triangles at the top of the
plot represent p values< 107. The shaded
region corresponds to the 95% concentra-
tion band as computed by the func-
tion qq.chisq of the R package
snp.matrix (see Web Resources).data problems: the quantile-quantile (Q-Q) plot of the
observedversus expectedpvalues for the allelic tests of asso-
ciation innephropathycases andcontrols showedanotable
excess of signiﬁcant p values at or below the level of 104
(Figure 1D). Because the initial QC tests of GoKinD data at
NCBI were performed with all available samples (including
related and duplicated individuals and those with different
self-reported ethnicity), we chose to repeat the analyses cor-
recting for these potential biases and conduct several addi-
tional QC tests.Moreover, the plate-effect test was based on
the GAINQC allelic association test with n  1 degrees of
freedom (df), where n is the total number of plates (n ¼ 34
in our case). Hence, although this test has identiﬁed
a number of SNPs with heterogeneity in allele-frequency
estimates across all plates, it was inappropriate for identi-
fying SNPs with biased allele frequencies on a single plate.
Therefore, we also designed a different test for plate effect.
We began with a set of unrelated probands who reported
themselves to be of recent European ancestry, and we pro-
ceeded with those samples that achieved a call rate of
>90% (1,661 of the original sample of 1,825) because
many of the QC studies use allele frequencies estimated
from the data in subsequent calculations, and sample
substructure can yield misleading results.11 As might be
expected in a data set this large, sex misspeciﬁcations
(two) and either duplicates or close relatives (eight, with
a pairwise proportion of identity by descent [IBD] estimate
bpR0:25) were identiﬁed with PLINK12 options sex-
check and genome, respectively, and removed, leaving
1651 samples for subsequent analyses. We also used PLINK
to estimate call rates by individual and by SNP, to calculate
average heterozygosity bH (across all SNPs) for each
individual, and to assess the ﬁt of the observed genotype
distributions for each SNP to those expected under Hardy-
Weinberg equilibrium (HWE) (Figure S1 available online).124 The American Journal of Human Genetics 87, 123–128, July 9, 2010We conducted plate-effect tests for
each plate separately by comparing
allele frequencies estimated for the
samples from a single plate to those
estimated for all other samples. Each
of these tests is a c2 test with 1 df, asopposed to the 33 df test run at NCBI, and therefore is
more appropriate for pinpointing problems with a partic-
ular plate. We identiﬁed plate 4RWG569 as having contrib-
uted disproportionately to the excess of signiﬁcant plate-
effect p values (Figure 1A); in particular, 732 autosomal
SNPs were signiﬁcantly associated (p value < 107) with
it, in stark contrast to the rest of the plates, in which the
median number of plate-associated SNPs at the level of
107 or below was equal to four. In plate-effect analyses,
as well as in the subsequent analysis of the primary pheno-
type, we employed a basic test of allelic association as im-
plemented in PLINK. SNPs with minor allele frequency
(MAF) <1% and X-linked SNPs were omitted.
We also discovered a pattern of genetically impossible
relationships among a set of eight individuals; any pair of
individuals in the set had a bp value of just under 0.25, and
estimated probabilities P(IBD ¼ 2)z 0.25, P(IBD ¼ 1)z 0,
and P(IBD ¼ 0) z 0.75. The bH values were signiﬁcantly
higher for these same individuals (on average, 42% versus
32% for the rest of GoKinD subjects, leading to a two-
sample t test p value <1013). In addition, these eight
individuals were estimated to be related to all other indi-
viduals in the sample at about the level of a second cousin
(P(IBD¼ 2)z 0, P(IBD¼ 1)z 0.25, and P(IBD¼ 0)z 0.75;
bpz0:125). A key observation was that all eight samples in
question were genotyped on the same plate, 4RWG569.
A preliminary GWA analysis of the nephropathy pheno-
type conducted on the 1651 samples comprising 804 cases
and 847 controls also revealed an excess of SNPs with asso-
ciation p value of <104. Moreover, we observed three
SNPs (denoted as triangles on Figures 1D and 1E) meeting
genome-wide criteria for signiﬁcance (p value < 108).
Notably, all of these SNPs had signiﬁcantly different esti-
mates of allele frequency on plate 4RWG569 than on other
plates (p value < 10200).
A B C D E
Figure 2. Normalized Signal-Intensity Plots Showing Allele-Frequency Distortion Caused by the Cluster of Problem Samples
The top row corresponds to the original assignment of genotypes on the plate; the bottom row corresponds to the same plate recalled
without the problem samples. The SNPs were chosen to have a highly signiﬁcant plate bias in the original data (p value < 1011).
(A) A typical conﬁguration for a failed Sty SNP in which only the eight problem samples were assigned incorrect genotypes (included
for comparison). The other plots represent several conﬁgurations leading to genotype misspeciﬁcations for the entire plate: (B) an Sty
SNP, (C) an Nsp SNP, (D) an Nsp/Sty SNP with the effect similar to an Nsp SNP, and (E) an Nsp/Sty SNP showing the effect of a single
sample misclassiﬁed as a new cluster. The SNP in (D) is one of three that meets genome-wide criteria for signiﬁcance (p value < 108)
in the original data.We hypothesized that the eight ‘‘problem’’ samples were
likely to have contributed to the excess of signiﬁcant asso-
ciation with the primary phenotype (Figure 1D) because all
of themwere assigned a nephropathy case status. However,
removing them from the analysis did not correct the
problem. After the eight samples were removed, the overall
excess of SNPs associated with both primary phenotype
and plate was largely unchanged (Figures 1B and 1E),
although the total number of SNPs with highly signiﬁcant
(p value < 107) allele frequency differences on plate
4RWG569 dropped to 28 (from 732).
Tohelpelucidate the sourceofdifferential allele frequency
bias,we constructed cluster plots for the 28 SNPswith stron-
gest plate association by using normalized allele intensities
(so-called allele A and B signals). We obtained the allele A
and B signals from available .CEL ﬁles by using the apt-
probeset-genotype application of the Affymetrix
Power Tools (APT) software package (see Web Resources).
On the basis of our analysis of cluster plots, we concluded
that the reason behind the differential plate bias was
extreme allele frequency distortion in genotype calls for all
samples on this plate and that this distortion was caused
by abnormal clustering of the eight poor-quality samples.
Typical patterns of MAF distortion are shown in Figures
2B–2E; the remaining cluster plots appear in Figure S2, avail-
able online.
Differential genotyping bias has been shown to drive the
false-positive rate in previous studies;13,14 here we found
that the distortion in genotype calls was exacerbated by
the imbalance of cases (83 out of 86 samples) on the plate.The AThis combination led to the excess of false-positive signals in
the primary phenotype analysis. In order to correct this bias,
we had to recall the genotypes for all samples on the after
removing the eight bad ones. The subsequent test for plate
and genotype association and primary phenotype GWA
study showed marked improvement in the number of false
positives (Figures 1C and 1F): only ﬁve SNPs crossed the
threshold for signiﬁcant plate association, which is consis-
tent with chance variability, and the overall excess of signif-
icant signals, including evidence for genome-wide signiﬁ-
cantassociationswithnephropathy,disappeared (Figure1F).
Because of how dramatically a small number of low-
quality samples within an otherwise high-quality set called
by plate can affect genotype calls, it is critical to identify
poorly performing samples before genotypes are called
even when the source of the quality problem in the
samples is not immediately obvious. Although the normal-
ized allele intensities proved indispensable in pinpointing
the source of differential bias, these alone are not sufﬁcient
to allow detection of the problematic samples prior to
allele calling and, in fact, may look misleadingly ‘‘normal’’
(see Figure S3) even for the most egregious samples.
Instead, we resorted to using raw (pre-normalized) inten-
sity data.
Twomethods of identifying and ﬁltering out low-quality
DNA samples prior to allele calling were applied to GoKinD
data. The ﬁrst method, referred to as Contrast QC (CQC),
was developed by Affymetrix in the context of QC assess-
ment of the SNP Array 6.0 data and implemented in
the Genotyping Console (GTC) 2.1 and APT packagesmerican Journal of Human Genetics 87, 123–128, July 9, 2010 125
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Figure 3. Log-Transformed Probe-Intensity and -Contrast
Distributions for the Samples on Plate 4RWG569
The top row corresponds to the panel of Nsp-speciﬁc SNPs, and the
bottom row corresponds to the panel of Sty-speciﬁc SNPs. Solid
black curves represent the eight samples with Sty target-prepara-
tion failure. In addition to these, one more sample identiﬁed by
SQC and CQC as failing on both Sty and Nsp panels appears in
all four plots and is especially evident in (A) and (B).(application apt-geno-qc). For each SNP, a CQC
metric deﬁned as a function of the allelic contrast
a ¼ IA  IB
IA þ IB
measures the extent of separation of allele intensities into
three clusters of AA, AB, and BB genotypes. Here, IA and IB
are the median raw intensity values for the allele A and B
probeset, respectively. CQC summary scores are calculated
for four pre-selected panels: a random set of 9,340 SNPs for
testing the overall quality of the sample, two sets of 20,000
enzyme-speciﬁc (Nsp or Sty) SNPs, and a set of 20,000 SNPs
occurring on both Nsp and Sty fragments. The enzyme-
speciﬁc panels appear to have been selected to include
the tails of the distribution of the restriction fragment
lengths for the entire set of enzyme-speciﬁc SNPs (see
Figure S4) so that the information obtained from a smaller
set of SNPs can be maximized. According to the Affymetrix
white paper (see Web Resources), CQC score values below
0.4 correspond to insufﬁcient cluster separation and thus
to a low call rate. In addition, a difference of 2.0 or greater
between the enzyme-speciﬁc scores indicates a possible
single-enzyme target preparation failure. We employed
the latter feature to detect problems with sample quality
prior to recalling genotypes.
In order for the application to work with the GoKinD
SNP Array 5.0 data, the .QCC library ﬁle containing pre-
selected panels of Array 6.0 SNPs was modiﬁed to include
only a subset of the panel SNPs represented on the SNP
Array 5.0 platform such that on the 5.0 platform these
SNPs were assayed with a probe pair from the same strand
and offset (such probes are so-called paired probes). The re-
sulting SNP Array 5.0 ‘‘partial’’ .QCC ﬁle contains 3,147
random, 3,532 Nsp-only, 2,952 Sty-only, and 4,477 Nsp/
Sty SNPs. We also constructed a ‘‘full’’ .QCC ﬁle based on
the information on SNP and enzyme pairing available in
the NetAffx annotation ﬁle and replaced the panel sets
with their counterparts from the entire collection of paired
probes. Both the partial and the full .QCC ﬁles are available
upon request from the authors.
The second test, referred to as Skewness QC (SQC), is
based on the asymmetry of the log-transformed distribu-
tion of IA and IB values measured by Pearson’s skewness
coefﬁcient S ¼ ðmeanmedianÞ=SD, where mean, median,
and SD are calculated over the combined set of log-trans-
formed IA and IB values. We applied this test to the
enzyme-speciﬁc SNP panels deﬁned above and observed
that typical values of s lie in the range of 0.1 < s < 0.1;
outliers are mostly in the direction of high positive s (skew-
ness to the right), corresponding to an excess of low-inten-
sity probes. If both sNsp and sSty have this property, it might
indicate an overall low sample quality or, if only one of the
enzyme-speciﬁc scores is out of bounds, a single target-
preparation failure. Note that the range of values of s is
clearly speciﬁc to the data and SNP panel; hence, the
threshold of 0.1 above should not be viewed as a universal
cutoff but rather as a suggestive value.126 The American Journal of Human Genetics 87, 123–128, July 9, 20We applied SQC and CQC tests to the GoKinD data by
using both the partial and full SNP panels (for results, see
Table S1). In all four scenarios, the eight problem samples
were successfully identiﬁed as having a single-enzyme (Sty)
target preparation failure, which probably caused the
majority of Sty-speciﬁc SNP probes to display low signal
intensity (that is, the low signal detected was actually
just background noise) (Figures 3C and 3D). This had
a profound impact on the genotype calls, not only for
the affected Sty SNPs (Figures 2A and 2B) but also, surpris-
ingly, for the Nsp and Nsp/Sty SNPs as well (Figures 2C and
2E): because probes from the same chip were normalized
together, the failed Sty-speciﬁc ones pushed some of the
moderate-intensity Nsp probes corresponding to heterozy-
gous genotypes to the upper tail of the distribution. This
created an artiﬁcial new cluster of homozygous genotypes,
which are especially evident in Figures 2C and 2D, top row,
and completely absent in Figures 2C and 2D, bottom row.
As a result, the cluster that would otherwise be assigned
a common homozygous genotype was misclassiﬁed as
heterozygous; with even more severe consequences, the
cluster of heterozygous genotypes was misclassiﬁed as
homozygous for the rare allele. Thus, for these SNPs not
only the genotypes for the problem samples but also the
genotypes for the rest of the samples on the plate were
grossly misspeciﬁed. Recalculating PLINK estimates of
average heterozygosity and IBD proportions for Sty- and
Nsp-speciﬁc SNPs separately conﬁrmed (Table 1) that Sty
failure was probably responsible for the deviations
observed in these characteristics for the eight problem
samples.10
Table 1. The Effect of Sty-Specific SNP Failure on the Estimates of Average Heterozygosity bH and Pairwise IBD Proportions bp
Enzyme- Specific
SNP Set











Sty 0.704 5 0.002 0.317 5 0.005 0.952 5 0.004 0.320 5 0.074 0.015 5 0.013
Nsp/Sty 0.400 5 0.003 0.319 5 0.005 0.147 5 0.005 0.102 5 0.011 0.007 5 0.008
Nsp 0.309 5 0.003 0.321 5 0.006 0.0 5 0.0 0.0 5 0.0 0.008 5 0.011In addition to the eight samples discussed above, a few
others were identiﬁed as having failed for one or both
enzymes (see Table S1). These additional failed samples
were distributed one or two per plate and did not alter
the overall allele calls sufﬁciently to show plate effects
above background. However, our collective experience
with GWAS QC suggests that as few as one failed sample
can lead to altered allele calls for an entire plate; moreover,
in someGWASwhere genotypes were called over the entire
sample, we observed (data not shown) that failed samples
from different plates could cluster together and, hence,
lead to a similar genotype-call distortion, this time
affecting the entire study. Thus, it is imperative to identify
and remove all failed samples (whatever the cause and
number) before genotype calling. We also note that the
GoKinD data set, and others on which we have conducted
QC studies, have plate effects that we have been unable to
explain. The magnitude of these plate effects is sufﬁciently
large and the observation sufﬁciently common to justify
more research in this area.
In conclusion, our studies suggest that it is often insufﬁ-
cient to simply remove samples lying outside common
quality-control thresholds. Such actions might fail to iden-
tify—or ﬁx—more fundamental problems affecting much
more of the data, and removal of just the poorest-quality
samples might make it more difﬁcult to identify the actual
cause of the problems. Clearly, unusual patterns of related-
ness and outlier heterozygosity rates across SNPs can be
useful clues about underlying data-quality problems that
might extend beyond those samples, and the one-degree-
of-freedom test for differential plate bias in allele-
frequency estimates is a useful approach for identifying
plates with potentially problematic data. Proper experi-
mental design, such as randomizing cases and controls to
plates, would also have attenuated the most egregious of
the effects that the plate bias caused in the primary associ-
ation analyses. The resulting higher genotype error rate in
cases and controls would be expected to both reduce power
and increase the number of false-positive associations. In
addition, genotyping error could be detected and poten-
tially accounted for by the use of duplicate genotyp-
ing.15–17 However, because many current GWAS are de-
signed to make use of samples from public databases,
investigators obtaining such data rarely have input into
the design of the original study or access to intended dupli-
cate genotypes. And so, for many investigators, recalling
genotypes after detecting and removing failed samplesThe Aremains the most effective way of eliminating this source
of genotyping bias.
Conducting association studies in which genotype data
for cases and controls have been generated at different
genotyping centers and/or at different times certainly
enhances the opportunity for plate biases in allele
frequency estimation to generate higher rates of false-posi-
tive results. It is therefore critical for both individual inves-
tigators and public data resources to keep and make
publicly available all of the data needed to assign
genotypes, particularly the probe-intensity ﬁles. Ideally,
those responsible for releasing data publicly would re-
examine data released before such measures were available
and analyze the probe-intensity data by using the CQC or
SQC (or similar) measures to identify samples that might
have a compromised genotype assignment, remove poor-
quality samples, and recall genotypes as indicated.
At the least, maintaining and/or providing upon request
pre- and post-normalization intensity data will ensure
that investigators are able to identify and correct data-
quality problems that might impact the entire sample
but that are not recognized until after analysis. Similarly,
both standard reports from genotyping centers and publi-
cations should include information on the allele- calling
algorithm and version used for generating the genotype
data, as well as metrics (such as CQC or SQC) used for
determining which samples should be included in allele
calling.Supplemental Data
Supplemental Data include four ﬁgures and one table and are
available with this article online at http://www.cell.com/AJHG/.Acknowledgments
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